摘要
目的探讨脑梗死患者采用尼莫通联合复方丹参和右旋糖酐治疗的临床疗效。方法选取我院于2013年1月-2014年1月收治的98例脑梗死患者作为研究对象,随机分为对照组和观察组,各49例,对照组采用复方丹参联合右旋糖酐治疗,观察组采用尼莫通联合复方丹参和右旋糖酐治疗,比较两组患者的临床疗效及神经功能损伤评分。结果治疗后,观察组的神经功能损伤评分低于对照组神经功能损伤评分（P〈0.05）;观察组的总有效率（97.86%）高于对照组的总有效率（85.71%）,差异有统计学意义（P〈0.05）;均未出现严重的不良反应。结论脑梗死患者采用尼莫通联合复方丹参和右旋糖酐治疗的临床疗效确切,值得临床推广应用。
Objective To investigate the clinical efficacy of nimotop combined with fufangdanshen and dextran in treatment of cerebral infarction. Methods 98 cases of patients with cerebral infarction were selected as the research object,who were in our hospital from January 2013 to January 2014,and randomly divided into the control group and observation group（n=49）.The control group was given Fufangdanshen combined with dextran.Observation group were treated with nimotop combined with fufangdanshen and dextran.The clinical efficacy and neurological damage score were compared. Results After treatment,neurological injury score in the observation group was lower than that of the control group（P〈0.05）.The total efficiency of the observation group（97.86%） was higher than the control group in the total efficiency（85.71%）,the difference was significant（P〈0.05）,with statistical significance.There were no serious adverse reactions. Conclusion Effect of of nimotop combined with fufangdanshen and dextran in treatment of cerebral infarction is effective,worthy of clinical application.
出处
《中国医药科学》
2015年第16期60-62,共3页
China Medicine And Pharmacy
